TrademarkDir
CIVI BIOPHARMA
LIVE

Serial Number

87982795

Owner

CiVi Biopharma, Inc.

Attorney

Brendan J. Hughes

First Use Date

Nov 18, 2019

Filing Date

Feb 16, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CIVI BIOPHARMA Trademark

Serial Number: 87982795 • Registration: 6037774

CIVI BIOPHARMA is a trademark filed by CiVi Biopharma, Inc. on February 16, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CiVi Biopharma, Inc. (2 trademarks)

One Town Place, 2nd Floor
Bryn Mawr, PA 19010

Entity Type: 03

Trademark Details

Filing Date

February 16, 2018

Registration Date

April 21, 2020

First Use Anywhere

November 18, 2019

First Use in Commerce

November 18, 2019

Published for Opposition

September 25, 2018

Goods & Services

Pharmaceutical preparations for the treatment of cardiovascular, metabolic and autoimmune diseases and related disorders

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 21, 2025 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 9, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 9, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 9, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 9, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 9, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 19, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 18, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 2, 2020 SUPC
DIVISIONAL PROCESSING COMPLETE
Mar 2, 2020 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 2, 2020 AITU
USE AMENDMENT FILED
Jan 29, 2020 IUAF
DIVISIONAL REQUEST RECEIVED
Jan 29, 2020 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jan 29, 2020 ERTD
TEAS STATEMENT OF USE RECEIVED
Jan 29, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 22, 2019 EXRA
SOU EXTENSION 2 GRANTED
Nov 20, 2019 EX2G
SOU EXTENSION 2 FILED
Nov 20, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 20, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 21, 2019 EXRA
SOU EXTENSION 1 GRANTED
May 17, 2019 EX1G
SOU EXTENSION 1 FILED
May 17, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
May 17, 2019 EEXT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 25, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 25, 2019 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 20, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 25, 2018 NPUB
PUBLISHED FOR OPPOSITION
Sep 25, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 5, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 21, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2018 CRFA
ASSIGNED TO LIE
Jul 23, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 9, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 5, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 5, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 5, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 1, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2018 NWOS
NEW APPLICATION ENTERED
Feb 20, 2018 NWAP

Related Trademarks

More from this Owner

CIVI BIOPHARMA

CIVI BIOPHARMA

CIVI BIOPHARMA

CIVI BIOPHARMA